A Twitter user @DopeFloat in a post on a microblogging site alleged that the hospital "charged Rs 18 lakh" for 15 days of treatment of dengue for a young daughter of his friend.
The tweet later went viral on social media.
"One of my batchmate's 7 year old was in @fortis_hospital for ~15 days for Dengue. Billed 18 lakhs including for 2700 gloves. She passed away at the end of it...," he tweeted.
Meanwhile, Fortis hospital in a statement claimed that "all standard medical protocols were followed in treating the patient and all clinical guidelines were adhered to".
"She was admitted with Severe Dengue which progressed to Dengue shock syndrome and was managed on IV fluids and supportive treatment as there was a progressive fall in platelet count and hemoconcentration.
"As her condition deteriorated, she had to be put on ventilatory support within 48 hours," the hospital said in a statement.
The hospital said an itemised bill "spread over 20 pages was explained and handed over to the family" at the time of their departure from the hospital.
All consumables are transparently reflected in records and charged as per actuals, it claimed.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
